Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force.
Saved in:
| Title: | Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force. |
|---|---|
| Authors: | Goldberg JF; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York., McIntyre RS; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Swartz HA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Freeman MP; Department of Psychiatry, Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, Boston.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Mago R; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York.; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Citrome L; Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla., Rosenblat JD; Department of Psychiatry and Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada., Thase ME; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania., Tohen M; Department of Psychiatry & Behavioral Sciences, University of New Mexico, Albuquerque., Vieta E; Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Institute of Neurosciences (UBNeuro), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biomedical Research Networking Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Department of Medicine, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Malhi GS; Academic Department of Psychiatry, Kolling Institute, Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; CADE Clinic and Mood-T, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; Oxford Uehiro Centre for Practical Ethics, Faculty of Philosophy, University of Oxford, Oxford, United Kingdom., Sajatovic M; Department of Psychiatry and of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio.; Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Shelton RC; Department of Psychiatry and Behavioral Neurobiology, University of Alabama Heersink School of Medicine, Birmingham., Macaluso M; Department of Psychiatry and Behavioral Neurobiology, University of Alabama Heersink School of Medicine, Birmingham., Berk M; Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Barwon Health, Geelong, Victoria, Australia.; Mental Health, Drugs and Alcohol Service, Barwon Health, Geelong, Victoria, Australia., Perlis RH; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.; Center for Quantitative Health, Massachusetts General Hospital, Boston., Ostacher MJ; Department of Veterans Affairs, Washington, DC.; School of Medicine, Stanford University, Stanford, California., Khan A; Northwest Clinical Research Center, Bellevue, Washington., Iosifescu DV; Nathan Kline Institute, Orangeburg, New York.; New York University Grossman School of Medicine, New York., Sanacora G; Department of Psychiatry, Yale University, Yale-New Haven Hospital, New Haven, Connecticut., Rubio JM; The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, New York., Kane JM; The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, New York., Goodman DW; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland.; Department of Psychiatry, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, New York., Nierenberg AA; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.; Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Harvard Medical School, Boston., Correll CU; The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany., Kupka R; Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, Netherlands., Kasper S; Department of Psychiatry and Psychotherapy, Clinical Division of General Psychiatry, Medical University of Vienna, Vienna, Austria.; Center for Brain Research, Department of Molecular Neuroscience, Medical University of Vienna, Vienna, Austria., Furukawa TA; Kyoto University Office of Institutional Advancement and Communications, Kyoto University, Kyoto, Japan., Davis L; Department of Psychiatry and Behavioral Neurobiology, University of Alabama Heersink School of Medicine, Birmingham., Aaronson ST; Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland., Gitlin MJ; Department of Psychiatry, Geffen School of Medicine at UCLA, Los Angeles, California., Jha MK; Center for Depression Research and Clinical Care, Peter O'Donnell Jr Brain Institute, Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas., Cohen LJ; Department of Pharmacotherapy, University of North Texas System College of Pharmacy, Fort Worth.; Department of Medical Education, Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth., Papakostas GI; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.; Department of Psychiatry, Clinical Trials Network and Institute, Massachusetts General Hospital, Boston., Mitchell PB; Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Gorwood P; Université Paris Cité, INSERM U1266, Institute of Psychiatry and Neurosciences of Paris (IPNP), Paris, France.; GHU Paris Psychiatrie et Neurosciences (CMME, Sainte-Anne Hospital), Paris, France., Gupta S; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.; Castle Point VA Medical Center, Wappingers Falls, New York., Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Young AH; Centre for Affective Disorders (CfAD), Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom., Zohar J; Psychiatric Division, Chaim Sheba Medical Center, Tel Hashomer, Israel., Steingard S; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington., Zarate CA Jr; Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland., Clayton AH; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville. |
| Corporate Authors: | American Society of Clinical Psychopharmacology Task Force on the Deprescribing of Psychotropic Medications |
| Source: | JAMA network open [JAMA Netw Open] 2026 Feb 02; Vol. 9 (2), pp. e260043. Date of Electronic Publication: 2026 Feb 02. |
| Publication Type: | Consensus Statement; Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
